Abstract:The field of syndromology spans a vast range of different and exciting research areas. Many famous clinical geneticists have laid the groundwork for today's landscape of syndromology. They described the clinical landscape of rare syndromes and started to unravel the underlying genetic causes. The advent of next generation sequencing technologies has led to the discovery of many novel disease-associated genes. This enabled clinical geneticists to increase the diagnostic yield and enlarge patient cohorts, broaden the phenotypic and genotypic spectrum of rare diseases and dig deeper into the underlying pathogenetic mechanisms. In this issue, we want to give an overview of this impressive development of syndromology by assembling a potpourri of different lines of research. We focus on the evolving phenotypes of rare diseases and their clinical management in adulthood, the booming field of epimutations, and the most commonly used model systems for exploration of pathogenetic mechanisms. Some research groups have started to focus on describing the evolving phenotypes of rare genetic diseases into adulthood. The article by Ariane Schmetz and colleagues gives an overview of these adult phenotypes and emphasizes the need of further studies to improve counselling of families with young children and adults with rare syndromes. They describe the phenotypes of four adult individuals with Costello syndrome illustrating the high variability of neurocognitive outcome and documenting recurrent carcinomata in some individuals. Dorothee Maliszewski-Makowka and Dagmar Wieczorek describe the developments in and missions of the so-called "MZEB" ("Medizinische Zentren für Erwachsene mit Behinderungen"), which were founded to ensure that adults with multiple disabilities receive medical care in an interdisciplinary and multi-professional setting. They summarize the efforts of the MZEB in the LVR clinic in Bedburg-Hau and the Institute of Human Genetics of the Heinrich-Heine University Düsseldorf to employ genetic testing in adults with mental disabilities and developmental and psychiatric disorders. The article written by Bernhard Horsthemke addresses the growing role of epigenetics in rare diseases by illustrating the classification of epimutations. Despite the large number of disease-associated chromatin modifier genes, for which he gives a comprehensive overview, the pathogenetic mechanisms remain to be elucidated. He concludes that the disease-relevant loci affected by the mutated chromatin modifier genes and their pathogenetic mechanisms are unknown and gives a critical outlook on the clinical application of newly developed epigenome editing tools. Different model systems are needed to gain insight into these and other pathogenetic mechanisms leading to syndromic diseases, to validate novel disease genes and variants of unknown significance and to assess potential therapeutic means for these rare diseases in a pre-clinical setting. The article by Anne Gregor and Christiane Zweier compiles the most commonly used models and outlines their application areas, as well as their advantages and limitations. We want to thank all authors for their valuable contributions and hope that the selected topics provide enticing insights into the recent developments in syndromology. 1 Centre of Medical Genetics, University and University Hospital Münster, Muenster, Germany 2 Institute of Human Genetics, Medical Faculty and University Hospital Düsseldorf, Heinrich Heine University Düsseldorf, Germany 3 Center for Rare Diseases, Medical Faculty and University Hospital, Dusseldorf, Heinrich Heine University Düsseldorf, Germany PD Dr. med. Nuria C. Bramswig Univ.-Prof. Dr. med. Dagmar Wieczorek © 2024 the author(s), published by De Gruyter. This work is licensed under the Creative Commons Attribution 4.0 International License.

Syndromes and birth defects in art and antiquities: New perspectives on a familiar theme

The stories behind the art—Malformations and Hindu mythology

OP11.02: The natural history in non‐obstructive congenital uterine anomalies: a prospective observational study in an unselected population

The Digital Atlas of Ancient Rare Diseases (DAARD) and its relevance for current research

Mapping the current status and outlook of research on noonan syndrome over the last 26 years: a bibliometric and visual analysis

Understanding and attitude to birth defects in modern China

Congenital Malformations of the Eye: A Pictorial Review and Clinico-Radiological Correlations

Understanding the Genetic and Non-Genetic Interconnections in the Aetiology of Syndromic Congenital Heart Disease: An Updated Review: Part 2

Syndromology at the interface of evolving phenotypes, epimutations, and model systems

Anatomic parameters of omphaloceles and their association with anatomic, genetic, or syndromic malformations: a retrospective study

Éléments de données communs pour l'arthrogrypose multiple congénitale: Un cadre international

Primary Prevention of Congenital Anomalies: Special Focus on Environmental Chemicals and other Toxicants, Maternal Health and Health Services and Infectious Diseases

Unraveling Patterns of Congenital Structural Malformations in Infants: A Hospital-Based Descriptive Study

What is new in obstetric antecedents of chronic disease? Best articles from the past year

The Myhre Syndrome Foundation as a global modern support group: The business of rare

New approaches to the study of disease in archeological New World populations.

Predicting Syndromic Status Based on Longitudinal Data from Parental Reports of the Presence of Additional Structural and Functional Anomalies in Children Born with an Orofacial Cleft

Congenital syphilis in the twenty-first century: an area-based study

Contrasting selected reproductive challenges of today with those of antiquity--the past is prologue

A comparative retrospective study on the prevalence and therapeutic treatment of dental agenesis between healthy children and children with systemic disease or congenital malformation

The Discovery of Common Chromosome Aneuploidies with Medical Implications Through Innovative Analysis of Ancient DNA (aDNA)